BE1003200A4 - Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE1003200A4
BE1003200A4 BE8900400A BE8900400A BE1003200A4 BE 1003200 A4 BE1003200 A4 BE 1003200A4 BE 8900400 A BE8900400 A BE 8900400A BE 8900400 A BE8900400 A BE 8900400A BE 1003200 A4 BE1003200 A4 BE 1003200A4
Authority
BE
Belgium
Prior art keywords
signifies
formula
group
residue
hydrogen
Prior art date
Application number
BE8900400A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808442A external-priority patent/GB8808442D0/en
Priority claimed from GB888826452A external-priority patent/GB8826452D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1003200A4 publication Critical patent/BE1003200A4/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE8900400A 1988-04-11 1989-04-10 Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments. BE1003200A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8808442 1988-04-11
GB888808442A GB8808442D0 (en) 1988-04-11 1988-04-11 Peptide derivatives
GB888826452A GB8826452D0 (en) 1988-11-11 1988-11-11 Peptide derivatives
GB8826452 1988-11-11

Publications (1)

Publication Number Publication Date
BE1003200A4 true BE1003200A4 (fr) 1992-01-14

Family

ID=26293760

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900400A BE1003200A4 (fr) 1988-04-11 1989-04-10 Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments.

Country Status (14)

Country Link
JP (1) JPH01305098A ( )
AU (1) AU3263989A ( )
BE (1) BE1003200A4 ( )
CH (1) CH677795A5 ( )
DE (1) DE3910667A1 ( )
DK (1) DK171489A ( )
ES (1) ES2013431A6 ( )
FR (1) FR2629824B1 ( )
GB (1) GB2224280B ( )
IL (1) IL89897A0 ( )
IT (1) IT1231943B ( )
LU (1) LU87496A1 ( )
NL (1) NL8900882A ( )
SE (1) SE8901278L ( )

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002262A1 (en) * 1977-12-01 1979-06-13 Merck & Co. Inc. Somatostatin analogs and process for their preparation
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives
EP0215171A2 (en) * 1985-09-12 1987-03-25 The Administrators Of The Tulane University Educational Fund Peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002262A1 (en) * 1977-12-01 1979-06-13 Merck & Co. Inc. Somatostatin analogs and process for their preparation
EP0187622A2 (en) * 1985-01-07 1986-07-16 Sandoz Ag Somatostatin derivatives
EP0215171A2 (en) * 1985-09-12 1987-03-25 The Administrators Of The Tulane University Educational Fund Peptides

Also Published As

Publication number Publication date
IT8947833A0 (it) 1989-04-10
FR2629824B1 (fr) 1995-03-10
NL8900882A (nl) 1989-11-01
SE8901278D0 (sv) 1989-04-10
LU87496A1 (fr) 1989-11-14
DK171489A (da) 1989-10-12
IL89897A0 (en) 1989-12-15
FR2629824A1 (fr) 1989-10-13
ES2013431A6 (es) 1990-05-01
IT1231943B (it) 1992-01-16
JPH01305098A (ja) 1989-12-08
DK171489D0 (da) 1989-04-10
CH677795A5 ( ) 1991-06-28
GB8907902D0 (en) 1989-05-24
GB2224280B (en) 1992-07-08
GB2224280A (en) 1990-05-02
AU3263989A (en) 1989-10-12
DE3910667A1 (de) 1989-10-19
SE8901278L (sv) 1989-10-12

Similar Documents

Publication Publication Date Title
BE1003752A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
BE1004357A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
LU87633A1 (fr) Derives peptidiques
JPH0784424B2 (ja) チロシン誘導体及びその用途
LU86697A1 (fr) Nouveaux derives de la calcitonine,leur preparation et leur utilisation comme medicaments
LU87262A1 (fr) Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments
CH655936A5 (fr) Derives du 3-amino pregn-5-ene, leurs sels, leur preparation, medicaments et compositions les renfermant.
BE1004038A4 (fr) Nouvelle utilisation therapeutique d'analogues ou de derives de la somatostatine.
BE1004645A3 (fr) Nouvelle utilisation therapeutique de peptides derives de la somatostatine.
BE1003200A4 (fr) Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments.
LU87952A1 (fr) Compositions pharmaceutiques de somatostatine a biodisponibilite amelioree
WO1988000594A1 (fr) Tetrapeptide inhibiteur de l'entree en cycle des cellules souches hematopoietiques, procedes pour son obtention et ses applications
BE897546A (fr) Nouveaux polypeptides leur preparation et leur application comme medicaments
FR2522655A1 (fr) Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
FR2548187A1 (fr) Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides
BE1003762A3 (fr) Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives.
FR2531952A1 (fr) Analogues a forte activite gonadotrope du facteur liberant l'hormone luteinisante et l'hormone folliculostimulante et leur procede de preparation
FR2957597A1 (fr) Cyclopeptides synthetiques, procede de preparation et utilisations
BE839405A (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2521133A1 (fr) Nouvel heptadecapeptide a effet de liberation d'hormone de croissance et medicament le contenant
EP0115227B1 (fr) Nouveaux dérivés peptidiques, leur procédé de fabrication et leur utilisation pharmaceutique
GB2227488A (en) Modified somatostatin
OA10136A (fr) Dérivés de la sorbine procédé pour la synthèse de ces peptides et compositions pharmaceutiques les contenant
FR2469395A1 (fr) Nouveau cyclopeptide, sa preparation et les medicaments qui le contiennent

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19960430